An overview of liposome lyophilization and its future potential
- PMID: 19874861
- DOI: 10.1016/j.jconrel.2009.10.024
An overview of liposome lyophilization and its future potential
Abstract
Lyophilization is a promising approach to ensure the long-term stability of liposomes. After decades of studies in this field, different lyoprotective mechanisms, such as water replacement and vitrification models, have been proposed. Much progress has been made in developing highly stable liposomes after lyophilization based on optimization of formulation and process parameters. Here, this paper reviews the lyoprotective mechanisms, the parameters affecting the lyoprotective effect and the techniques used in a large number of studies. The parameters are discussed with regard to the following two aspects: (1) the formulation factors: the choice of drug, the lipid bilayer composition, vesicle size, selection of lyoprotectants, combination of lyoprotectants and additives, dry mass ratio of lyoprotectant to lipid, distribution of lyoprotectant on the two sides of lipid bilayers and others, which are the key factors determining the lyoprotective effect of freeze-dried liposomes. (2) The technological factors: freezing protocols, drying protocols, storage conditions and others, which are the extrinsic factors affecting the stability of freeze-dried cakes. Moreover, encapsulated solute/drug retention (ESR), gel-to-liquid crystalline phase transition temperature (T(m)) and glass transition temperature (T(g)) are selected as indicators to investigate the protective effect during this process. Finally, the major areas and future potential of research on lyophilized liposomes are highlighted.
(c) 2009 Elsevier B.V. All rights reserved.
Similar articles
-
The effects of lyophilization on the stability of liposomes containing 5-FU.Int J Pharm. 2005 Mar 3;291(1-2):79-86. doi: 10.1016/j.ijpharm.2004.07.045. Epub 2005 Jan 13. Int J Pharm. 2005. PMID: 15707734
-
Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure.Eur J Pharm Sci. 2010 Nov 20;41(3-4):546-55. doi: 10.1016/j.ejps.2010.08.010. Epub 2010 Aug 26. Eur J Pharm Sci. 2010. PMID: 20800680
-
Amino acids as cryoprotectants for liposomal delivery systems.Eur J Pharm Sci. 2007 Apr;30(5):406-13. doi: 10.1016/j.ejps.2007.01.001. Epub 2007 Jan 19. Eur J Pharm Sci. 2007. PMID: 17317117
-
Stabilization of liposomes during drying.Expert Opin Drug Deliv. 2011 Mar;8(3):375-88. doi: 10.1517/17425247.2011.553219. Epub 2011 Feb 4. Expert Opin Drug Deliv. 2011. PMID: 21294603 Review.
-
Factors affecting microencapsulation of drugs in liposomes.J Microencapsul. 1995 May-Jun;12(3):229-46. doi: 10.3109/02652049509010292. J Microencapsul. 1995. PMID: 7650588 Review.
Cited by
-
Long-Circulating and Fusogenic Liposomes Loaded with Paclitaxel and Doxorubicin: Effect of Excipient, Freezing, and Freeze-Drying on Quality Attributes.Pharmaceutics. 2022 Dec 27;15(1):86. doi: 10.3390/pharmaceutics15010086. Pharmaceutics. 2022. PMID: 36678715 Free PMC article.
-
A Comprehensive Review of mRNA Vaccines.Int J Mol Sci. 2023 Jan 31;24(3):2700. doi: 10.3390/ijms24032700. Int J Mol Sci. 2023. PMID: 36769023 Free PMC article. Review.
-
Liposome delivery systems for the treatment of Alzheimer's disease.Int J Nanomedicine. 2018 Dec 12;13:8507-8522. doi: 10.2147/IJN.S183117. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30587974 Free PMC article. Review.
-
Protective Effect of Saccharides on Freeze-Dried Liposomes Encapsulating Drugs.Front Bioeng Biotechnol. 2019 Dec 17;7:424. doi: 10.3389/fbioe.2019.00424. eCollection 2019. Front Bioeng Biotechnol. 2019. PMID: 31921827 Free PMC article.
-
Nanotechnology of inhalable vaccines for enhancing mucosal immunity.Drug Deliv Transl Res. 2024 Mar;14(3):597-620. doi: 10.1007/s13346-023-01431-7. Epub 2023 Sep 25. Drug Deliv Transl Res. 2024. PMID: 37747597 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous